Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1714 USD | -1.27% |
|
+0.47% | -25.09% |
| Market Cap | 29Cr 25Cr 24Cr 22Cr 41Cr 2.76TCr 41Cr 280.51Cr 109.79Cr 1.37TCr 108.62Cr 106.27Cr 4.74TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 39Cr 34Cr 31Cr 29Cr 54Cr 3.68TCr 55Cr 373.66Cr 146.25Cr 1.83TCr 144.69Cr 141.56Cr 6.31TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.6x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.27% | ||
| 1 week | +0.47% | ||
| Current month | -8.24% | ||
| 1 month | -11.60% | ||
| 3 months | -14.26% | ||
| 6 months | -41.00% | ||
| Current year | -25.09% |
| 1 week | 0.17 |  | 0.18 |
| 1 month | 0.14 | | 0.2 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.37 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 10,00,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 30,00,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 10,00,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +0.47% | -31.88% | -67.77% | 29Cr | |
| -0.67% | +1.11% | +49.07% | +67.79% | 5.5TCr | |
| -1.32% | -2.71% | +34.27% | +77.57% | 5.42TCr | |
| +1.49% | +0.13% | -18.03% | -13.94% | 2.34TCr | |
| -0.57% | -4.13% | +2.34% | +387.73% | 2.26TCr | |
| +2.75% | +2.11% | +18.04% | -10.07% | 2.02TCr | |
| -0.72% | +3.00% | +27.41% | -29.52% | 1.79TCr | |
| -3.24% | -4.84% | +24.81% | +551.22% | 1.55TCr | |
| -6.69% | -5.11% | +169.13% | +304.89% | 1.42TCr | |
| +1.25% | +0.69% | +27.30% | +184.69% | 1.42TCr | |
| Average | -0.90% | -0.79% | +30.25% | +145.26% | 2.37TCr | |
| Weighted average by Cap. | -0.72% | -0.52% | +34.57% | +131.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 3.89Cr 3.42Cr 3.18Cr 2.93Cr 5.49Cr 371.96Cr 5.58Cr 38Cr 15Cr 184.47Cr 15Cr 14Cr 637.34Cr |
| Net income | - | - |
| Net Debt | 9.61Cr 8.43Cr 7.85Cr 7.22Cr 14Cr 917.9Cr 14Cr 93Cr 36Cr 455.22Cr 36Cr 35Cr 1.57TCr | 12Cr 11Cr 10Cr 9.39Cr 18Cr 1.19TCr 18Cr 121.13Cr 47Cr 591.95Cr 47Cr 46Cr 2.05TCr |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $0.1714 | -1.27% | 21,67,426 |
| 27/26/27 | $0.1736 | +1.12% | 17,09,184 |
| 24/26/24 | $0.1717 | +1.53% | 14,69,451 |
| 23/26/23 | $0.1691 | -2.69% | 14,11,252 |
| 22/26/22 | $0.1738 | +1.87% | 30,10,242 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1714USD
Average target price
1.000USD
Spread / Average Target
+483.46%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
